| dc.contributor.author | Burton, Martin J | |
| dc.contributor.author | Clarkson, Janet E. | |
| dc.contributor.author | Goulao, Beatriz | |
| dc.contributor.author | Glenny, Anne-Marie | |
| dc.contributor.author | McBain, Andrew J. | |
| dc.contributor.author | Schilder, Anne GM | |
| dc.contributor.author | Webster, Katie E. | |
| dc.contributor.author | Worthington, Helen V | |
| dc.date.accessioned | 2021-09-15T23:11:10Z | |
| dc.date.available | 2021-09-15T23:11:10Z | |
| dc.date.issued | 2020-09-16 | |
| dc.identifier | 176455613 | |
| dc.identifier | 50e6e76f-4a93-4cc2-9664-4439c4e11ca6 | |
| dc.identifier | 85091129745 | |
| dc.identifier | 000579343700009 | |
| dc.identifier.citation | Burton , M J , Clarkson , J E , Goulao , B , Glenny , A-M , McBain , A J , Schilder , A GM , Webster , K E & Worthington , H V 2020 , ' Use of antimicrobial mouthwashes (gargling) and nasal sprays by healthcare workers to protect them when treating patients with suspected or confirmed COVID‐19 infection ' , Cochrane Database of Systematic Reviews , vol. 2020 , no. 9 , CD013626 , pp. CD013626 . https://doi.org/10.1002/14651858.CD013626.pub2 | en |
| dc.identifier.issn | 1469-493X | |
| dc.identifier.uri | https://hdl.handle.net/2164/17085 | |
| dc.description | A C K N O W L E D G E M E N T S We would like to thank the peer reviewers, Professor Jeremy Bagg, Dr Karolin Hijazi, Professor Carl Philpott and Professor Claire Hopkins, for their insightful comments which helped us to improve these protocols. Thanks also to Professor Peter Tugwell, Senior Editor Cochrane MOSS Network, for acting as sign-oF editor for these projects. We are also grateful to Doug Salzwedel from the Cochrane HypertensionGroup for providing search peerreview comments for the draK search strategy. Professor Schilder's time for this project was supported by the National Institute for Health Research, University College London Hospitals Biomedical Research Centre, London, UK. This project was supported by the National Institute for Health Research, via Cochrane Infrastructure, Cochrane Programme Grant or Cochrane Incentive funding to Cochrane ENT and Cochrane Oral Health. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health. | en |
| dc.format.extent | 28 | |
| dc.format.extent | 326580 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Cochrane Database of Systematic Reviews | en |
| dc.subject | CORONAVIRUS | en |
| dc.subject | R Medicine | en |
| dc.subject | Pharmacology (medical) | en |
| dc.subject.lcc | R | en |
| dc.title | Use of antimicrobial mouthwashes (gargling) and nasal sprays by healthcare workers to protect them when treating patients with suspected or confirmed COVID‐19 infection | en |
| dc.type | Journal article | en |
| dc.contributor.institution | University of Aberdeen.Health Services Research Unit | en |
| dc.description.status | Peer reviewed | en |
| dc.identifier.doi | 10.1002/14651858.CD013626.pub2 | |
| dc.date.embargoedUntil | 2021-09-16 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85091129745&partnerID=8YFLogxK | en |
